Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)
CNY 87.32
(3.15%)
CNY 87.32
(3.15%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.86 Billion CNY | -297.05% |
| 2022 | -468.53 Million CNY | 23.19% |
| 2021 | -609.96 Million CNY | -72.49% |
| 2020 | -353.62 Million CNY | -25.14% |
| 2019 | -282.58 Million CNY | -7717.77% |
| 2018 | -3.61 Million CNY | -439.96% |
| 2017 | 1.06 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -715.9 Million CNY | -55.22% |
| 2024 Q2 | -461.63 Million CNY | 80.73% |
| 2024 Q1 | -2.39 Billion CNY | -28.8% |
| 2023 Q4 | -1.86 Billion CNY | -26.81% |
| 2023 FY | -1.86 Billion CNY | -297.05% |
| 2023 Q3 | -1.46 Billion CNY | -125.21% |
| 2023 Q1 | -533.63 Million CNY | -13.9% |
| 2023 Q2 | -651.38 Million CNY | -22.06% |
| 2022 Q2 | -1.01 Billion CNY | -49.42% |
| 2022 Q1 | -681.25 Million CNY | -11.69% |
| 2022 Q4 | -468.53 Million CNY | 53.22% |
| 2022 FY | -468.53 Million CNY | 23.19% |
| 2022 Q3 | -1 Billion CNY | 1.61% |
| 2021 Q2 | -549.64 Million CNY | 19.53% |
| 2021 Q3 | -958.76 Million CNY | -74.43% |
| 2021 FY | -609.96 Million CNY | -72.49% |
| 2021 Q1 | -683.06 Million CNY | -93.16% |
| 2021 Q4 | -609.96 Million CNY | 36.38% |
| 2020 Q1 | 946.98 Million CNY | 435.12% |
| 2020 FY | -353.62 Million CNY | -25.14% |
| 2020 Q4 | -353.62 Million CNY | -108.41% |
| 2020 Q3 | -169.67 Million CNY | -19.16% |
| 2020 Q2 | -142.39 Million CNY | -115.04% |
| 2019 FY | -282.58 Million CNY | -7717.77% |
| 2019 Q4 | -282.58 Million CNY | 0.0% |
| 2019 Q1 | 128.61 Million CNY | 0.0% |
| 2018 FY | -3.61 Million CNY | -439.96% |
| 2017 FY | 1.06 Million CNY | 0.0% |